Both in Pharmaceuticals
ANI Pharmaceuticals vs Kailera Therapeutics
Over the past year ANIP returned +2.2% and KLRA returned −9.4%; their daily moves had a correlation of 0.22.
ANIP +2.2% KLRA −9.4%Growth of $1, one year, split-adjusted
| Metric | ANIP | KLRA |
|---|---|---|
| Price | $71.71 | $12.64 |
| Market cap | $1.65B | $1.64B |
| Today | +1.47% | +3.99% |
| 1 month | −1.2% | +16.6% |
| 6 months | −15.3% | — |
| Year to date | −9.2% | — |
| 1 year | −20.8% | — |
| Revenue growth (YoY) | +25.9% | — |
| Gross margin | 62.4% | — |
| Net margin | 8.6% | — |
| P/E (TTM) | 16.5× | — |
| Price / sales | 1.7× | — |
| Net cash | -$234.7M | $916.7M |
| Dividend yield | — | — |
| Volatility (60d) | 26.6% | — |
| Short % of float | 18.1% | 9.1% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).